Latest Breaking News On - Professor mingchang zhang - Page 1 : comparemela.com

/PRNewswire/ Eluminex Biosciences today announced the completion of clinical enrollment in Part A (N=5) of a two-part pivotal study (CLARITY) evaluating a.

United statesSan diegoEluminex biosciencesMingchang zhangCharles sembaChina jiangsu medical product agencyAmerican society of cataractCorneal surgery at wuhan union hospitalInitial partAmerican societyRefractive surgery annualJiangsu medical product agencyGreater chinaRefractive surgeryProfessor mingchang zhangCorneal surgery